Methods and kits for predicting a response to an erythropoietic agent

Title: Methods and kits for predicting a response to an erythropoietic agent

Full Record
Similar

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent.

Inventors:: Merchant, Michael L.; Klein, Jon B.; Brier, Michael E.; Gaweda, Adam E.

Issue Date:: 2018-08-07

OSTI Identifier:: 1469316

Assignee:: University of Louisville Research Foundation, Inc. (Louisville, KY) CHO

Patent Number(s):: 10,041,956

Application Number:: 14/712,323

Contract Number:: FG02-05ER6406

Resource Relation:: Patent File Date: 2015 May 14

Research Org:: University of Louisville Research Foundation, Inc., Louisville, KY (United States)

Sponsoring Org:: USDOE

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES

Full Text
View Full Text

Similar records in DOepatents and OSTI.GOV collections:

Methods and kits for predicting a response to an erythropoietic agent

Patent Merchant, Michael L. ; Klein, Jon B. ; Brier, Michael E. ; Gaweda, Adam E.

Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent. Kits for predicting a response to an erythropoietic agent are further providedmore »« less
Full Text Available June 2015
Kits and methods of detection using cellulose binding domain fusion proteins

Patent Shoseyov, Oded

A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production thereof. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques.
Full Text Available January 1998
Methods and kits for nucleic acid analysis using fluorescence resonance energy transfer

Patent Kwok, Pui-Yan ; Chen, Xiangning

A method for detecting the presence of a target nucleotide or sequence of nucleotides in a nucleic acid is disclosed. The method is comprised of forming an oligonucleotide labeled with two fluorophores on the nucleic acid target site. The doubly labeled oligonucleotide is formed by addition of a singly labeled dideoxynucleoside triphosphate to a singly labeled polynucleotide or by ligation of two singly labeled polynucleotides. Detection of fluorescence resonance energy transfer upon denaturation indicates the presence of the target. Kits are also provided. The method is particularly applicable to genotyping.
Full Text Available January 1999
Methods, compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging

Patent Rose-Petruck, Christoph ; Wands, Jack R. ; Rand, Danielle ; Derdak, Zoltan ; Ortiz, Vivian

Methods, compositions, systems, devices and kits are provided herein for preparing and using a nanoparticle composition and spatial frequency heterodyne imaging for visualizing cells or tissues. In various embodiments, the nanoparticle composition includes at least one of: a nanoparticle, a polymer layer, and a binding agent, such that the polymer layer coats the nanoparticle and is for example a polyethylene glycol, a polyelectrolyte, an anionic polymer, or a cationic polymer, and such that the binding agent that specifically binds the cells or the tissue. Methods, compositions, systems, devices and kits are provided for identifying potential therapeutic agents in a modelmore »« less
Full Text Available April 2016
Methods, microfluidic devices, and systems for detection of an active enzymatic agent

Patent Sommer, Gregory J ; Hatch, Anson V ; Singh, Anup K ; Wang, Ying-Chih

Embodiments of the present invention provide methods, microfluidic devices, and systems for the detection of an active target agent in a fluid sample. A substrate molecule is used that contains a sequence which may cleave in the presence of an active target agent. A SNAP25 sequence is described, for example, that may be cleaved in the presence of Botulinum Neurotoxin. The substrate molecule includes a reporter moiety. The substrate molecule is exposed to the sample, and resulting reaction products separated using electrophoretic separation. The elution time of the reporter moiety may be utilized to identify the presence or absence ofmore » the active target agent.« less
Full Text Available October 2014